Published • loading... • Updated
FDA fills four senior roles, including top officials for drugs, vaccines and tobacco
The moves give the agency permanent leaders for drugs, vaccines and tobacco products and create a new post to oversee artificial intelligence and technology.
- On Tuesday, the administration of President Donald Trump filled four senior positions at the Food and Drug Administration, promoting acting officials to permanent roles to stabilize the agency.
- Months of upheaval preceded the changes, including departures of Tracy Beth Hoeg, Vinay Prasad, and Marty Makary, who faced scrutiny from industry executives and patient groups over policy shifts.
- Michael Davis will lead the Center for Drug Evaluation and Research, while Karim Mikhail assumes the vaccines center directorship and Bret Koplow takes the Center for Tobacco Products.
- Additionally, Jared Seehafer will serve in a newly created position overseeing artificial intelligence and technology, signaling expanded regulatory focus on emerging digital health tools.
- Leadership changes follow major policy shifts, with Health Secretary Robert emphasizing faster psychedelic reviews while the agency manages ongoing controversy over COVID-19 vaccine requirements and flavored e-cigarette regulations.
Insights by Ground AI
18 Articles
18 Articles
Associated Press News+17 Reposted by 17 other sources
FDA fills four senior roles, including top officials for drugs, vaccines and tobacco
The Trump administration named four officials to take over senior roles at the Food and Drug Administration, including the agency’s top leaders for drugs and vaccines.
·New York, United States
Read Full ArticleCoverage Details
Total News Sources18
Leaning Left9Leaning Right1Center6Last UpdatedBias Distribution56% Left
Bias Distribution
- 56% of the sources lean Left
56% Left
L 56%
C 38%
Factuality
To view factuality data please Upgrade to Premium
